Integrating Novel Developments for Advanced and Metastatic Breast Cancer into Improved Care Pathways

Integrating Novel Developments for Advanced and Metastatic Breast Cancer Into Improved Care Pathways Is Organized by Healthcare Made Practical (Hmp) Communications Llc and Will Be Held From Nov 21, 2018 - Nov 21, 2019.

This Cme Conference Has Been Approved for a Maximum of 0.75 AMA PRA Category 1 Credits.

Target Audience:
This Activity Is Designed for Directors of Oncology Practice Programs and Cancer Centers, Oncologists, Hematologists, Commercial and Government Payers, Pathway Development Executives, Reimbursement Specialists, Specialty Pharmacists, Heor Specialists, and Other Healthcare Professionals Interested in Learning How to Implement, Integrate, and Measure Treatment Pathways.

Learning Objectives:
• Summarize the Clinical and Socioeconomic Challenges Associated With Advanced and Metastatic Breast Cancer  
• Evaluate Clinical and Public Health Implications of Personalizing Treatment According to Gene Mutations and Molecular Disease Subtype 
• Outline Clinical Trial Evidence of Newer Therapeutic Options for Advanced and Metastatic Breast Cancer 
• Translate the Latest Evidence Regarding Advanced and Metastatic Breast Cancer Treatment Options, Current Guidelines, Available Cost Data, and Expert Recommendations Into Improved Breast Cancer Clinical Pathway Development and Adoption.

 Additional details will be posted as soon as they are available.